Picture of InspireMD logo

NSPR InspireMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: InspireMD Announces Approval Of Application For Pivotal Study Of The CGuard Prime 80Cm Carotid Stent System

Oct 7 (Reuters) - InspireMD Inc  NSPR.O :
    * INSPIREMD ANNOUNCES APPROVAL OF INVESTIGATIONAL DEVICE
EXEMPTION
(IDE) APPLICATION FOR CGUARDIANS II PIVOTAL STUDY OF THE CGUARD
PRIME 80CM CAROTID STENT SYSTEM

Source text for Eikon:  ID:nGNX5dtfdD 
Further company coverage:  NSPR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on InspireMD

See all news